98 related articles for article (PubMed ID: 6166404)
21. How can we improve the treatment of bone metastases further?
Coleman RE
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S7-13. PubMed ID: 9801853
[TBL] [Abstract][Full Text] [Related]
22. Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases.
Storto G; Klain M; Paone G; Liuzzi R; Molino L; Marinelli A; Soricelli A; Pace L; Salvatore M
Bone; 2006 Jul; 39(1):35-41. PubMed ID: 16434248
[TBL] [Abstract][Full Text] [Related]
23. Effect of calcitonin on the skeleton and bone pain in patients with osteolytic metastases.
Spaventi S; Vrbanec D
Acta Med Iugosl; 1987; 41(1):33-42. PubMed ID: 3604744
[No Abstract] [Full Text] [Related]
24. [Use of calcitonin in neoplastic osteolysis].
Pastorino G; Bianucci M
Minerva Med; 1983 Mar; 74(13):707-14. PubMed ID: 6835560
[TBL] [Abstract][Full Text] [Related]
25. [Palliation of bone pain in metastatic prostate carcinoma. Value of radionuclide therapy with rhenium 186 HEDP].
Klutmann S; Bohuslavizki KH
MMW Fortschr Med; 1999 Nov; 141(44):38-9. PubMed ID: 10912142
[TBL] [Abstract][Full Text] [Related]
26. [Biphosphonates in the treatment of bone metastasis of prostatic cancer].
Paule B; Cicco A
Prog Urol; 2001 Dec; 11(6):1205-12. PubMed ID: 11859653
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer bone metastases promote both osteolytic and osteoblastic activity.
Keller ET; Brown J
J Cell Biochem; 2004 Mar; 91(4):718-29. PubMed ID: 14991763
[TBL] [Abstract][Full Text] [Related]
28. Conventional radiograms for assessment of salm-calcitonin therapy for bone metastases from breast carcinoma.
Geyer J; Quadt C; Perlick E; Starke K; Stier G; Tanneberger S
Eur J Radiol; 1991; 12(2):124-6. PubMed ID: 2036999
[TBL] [Abstract][Full Text] [Related]
29. The systemic treatment of bone metastases.
Houston SJ; Rubens RD
Clin Orthop Relat Res; 1995 Mar; (312):95-104. PubMed ID: 7543393
[TBL] [Abstract][Full Text] [Related]
30. Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
Leondi AH; Souvatzoglou MA; Rapti AS; Leontopoulou SA; Papadaki EK; Datseris EI; Anagnostopoulou US; Zerva CJ
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):211-9. PubMed ID: 15499295
[TBL] [Abstract][Full Text] [Related]
31. Hypercalcemia and bone resorption in malignancy.
Walls J; Bundred N; Howell A
Clin Orthop Relat Res; 1995 Mar; (312):51-63. PubMed ID: 7634618
[TBL] [Abstract][Full Text] [Related]
32. Radiophosphorous (P32) treatment in carcinoma of the breast and prostate: report of 39 cases.
Miller AD
J Am Osteopath Assoc; 1974 Nov; 74(3):217-22. PubMed ID: 4139177
[No Abstract] [Full Text] [Related]
33. Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases.
Lindqvist O; Rasmussen BH; Widmark A
Eur J Oncol Nurs; 2008 Sep; 12(4):283-90. PubMed ID: 18440862
[TBL] [Abstract][Full Text] [Related]
34. [The evaluation of the effectiveness of half-body irradiation as palliative treatment in patients with multiple bone metastases].
Miszczyk L; Sasiadek W
Przegl Lek; 2001; 58(5):431-4. PubMed ID: 11603177
[TBL] [Abstract][Full Text] [Related]
35. The use of bisphosphonates in palliative treatment of bone metastases in a terminally ill, oncological elderly population.
Santangelo A; Testai M; Barbagallo P; Manuele S; Di Stefano A; Tomarchio M; Trizzino G; Musumeci G; Panebianco P; Maugeri D
Arch Gerontol Geriatr; 2006; 43(2):187-92. PubMed ID: 16325938
[TBL] [Abstract][Full Text] [Related]
36. Analgetic activity of calcitonin in patients with painful osteolytic metastases of breast cancer. Results of a controlled randomized study.
Roth A; Kolarić K
Oncology; 1986; 43(5):283-7. PubMed ID: 3531953
[TBL] [Abstract][Full Text] [Related]
37. Phosphorus 32 for intractable pain in carcinoma of the prostate.
Johnson DE; Haynie TP
Tex Med; 1971 Mar; 67(3):57-9. PubMed ID: 4103609
[No Abstract] [Full Text] [Related]
38. Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer.
Small EJ; Smith MR; Seaman JJ; Petrone S; Kowalski MO
J Clin Oncol; 2003 Dec; 21(23):4277-84. PubMed ID: 14581438
[TBL] [Abstract][Full Text] [Related]
39. Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis.
Vessella RL; Corey E
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6285s-6290s. PubMed ID: 17062715
[TBL] [Abstract][Full Text] [Related]
40. [Use of calcitonin in the treatment of bone metastases of prostatic carcinoma].
Di Silverio F; Giacobini S; Liberti M; Fragomeri R; Petrone U
Clin Ter; 1977 Oct; 83(1):3-15. PubMed ID: 589946
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
